Bristol-Myers Squibb Patient Assistance Foundation Inc is located in Princeton, NJ. The organization was established in 1999. According to its NTEE Classification (P58) the organization is classified as: Gift Distribution, under the broad grouping of Human Services and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Bristol-Myers Squibb Patient Assistance Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Bristol-Myers Squibb Patient Assistance Foundation Inc generated $3.0b in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 23.1% each year . All expenses for the organization totaled $2.9b during the year ending 12/2022. While expenses have increased by 22.2% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
Part 3 - Line 4a
SEE GENERAL EXPLANATION
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Alicia Coghlan Vice President | 1 | $0 | |
Amadou Diarra Trustee | 1 | $0 | |
Harvey Kaish Secretary (end 7/1/22) | 1 | $0 | |
John L Damonti President/chairman | 1 | $0 | |
Karim Munir Treasurer (end 10/7/22) | 1 | $0 | |
Nicholas Botwood Trustee (end 11/28/22) | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Amerisourcebergen Lash Group | 12/30/22 | $53,966,363 |
Rxcrossroads By Mckesson | 12/30/22 | $4,473,573 |
Clearview Healthcare Partners | 12/30/22 | $118,385 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $3,035,503,092 |
Interest on Savings | $0 |
Dividends & Interest | $0 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $0 |
Capital Gain Net Income | $0 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $3,035,503,092 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $0 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $0 |
Interest | $0 |
Taxes | $0 |
Depreciation | $0 |
Occupancy | $0 |
Travel, conferences, and meetings | $0 |
Printing and publications | $0 |
Other expenses | $5,178,591 |
Total operating and administrative expenses | $63,736,912 |
Contributions, gifts, grants paid | $2,863,865,112 |
Total expenses and disbursements | $2,927,602,024 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $0 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $0 |
Grants receivable | $5,208,670 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $229,554,350 |
Prepaid expenses and deferred charges | $0 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $0 |
Other assets | $0 |
Total assets | $234,763,020 |
Accounts payable and accrued expenses | $5,208,670 |
Grants payable | $0 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $5,208,670 |
Over the last fiscal year, Bristol-Myers Squibb Patient Assistance Foundation Inc has awarded $1,279,273,428 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
INDIVIDUAL PATIENT PROGRAMS PURPOSE: CARE OF QUALIFIED ILL, NEEDY, OR INFANTS - PRESCRIPTION DRUGS SHIPPED AT NO CHARGE TO PHYSICIANS AND PATIENTS | $1,278,470,693 |
INSTITUTIONAL PATIENT PROGRAMS PURPOSE: CARE OF QUALIFIED ILL, NEEDY, OR INFANTS - PRESCRIPTION DRUGS SHIPPED AT NO CHANGE TO QUALIFIED HEALTH PROVIDERS ON BEHALF OF ELIGIBLE PATIENTS | $802,735 |